Gary Jacob
Chief Executive Officer at OKYO PHARMA LIMITED
Net worth: 69 885 $ as of 30/03/2024
Profile
Gary S.
Jacob founded Synergy Pharmaceuticals, Inc. in 2008, where he worked as Chairman, President & Chief Executive Officer from 2013 to 2017.
Dr. Jacob also founded Synergy Pharmaceuticals LLC, where he worked as Executive Chairman from 2017 to 2018.
Dr. Jacob also currently works at OKYO Pharma Ltd., as Chief Executive Officer & Executive Director from 2021 and Actavia Life Sciences, Inc., as Independent Director from 2020.
Dr. Jacob also formerly worked at Callisto Pharmaceuticals, Inc., as President, Chief Executive Officer & Director from 2004 to 2013, Pawfect Foods, Inc., as President, Chief Executive Officer & Director in 2008, Immuron Ltd., as CEO, Non-Executive Director & Managing Director from 2019 to 2020, Hepion Pharmaceuticals, Inc., as Chairman from 2014 to 2024, Synergy DE, as Chairman in 2008, Monsanto Co., as Director-Functional Genomics, Science & Technology from 1997 to 1998, Cardiff Oncology, Inc., as Independent Director from 2012 to 2021, G.D.
Searle LLC, as Glycobiology Director from 1990 to 1997, Virpax Pharmaceuticals, Inc., as Independent Director from 2020 to 2022, and the University of Oxford, as Manager-Searle Glycobiology Group in 1990.
Dr. Jacob received his doctorate degree from the University of Wisconsin and undergraduate degree from the University of Missouri-St. Louis.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
OKYO PHARMA LIMITED
0.14% | 27/07/2023 | 45,883 ( 0.14% ) | 68 366 $ | 30/03/2024 |
| 18/02/2024 | 610 ( 0.01% ) | 1 519 $ | 30/03/2024 | |
| 14/12/2023 | 0 ( -.--% ) | - $ | 30/03/2024 |
Gary Jacob active positions
| Companies | Position | Start |
|---|---|---|
| ACTAVIA LIFE SCIENCES, INC. | Director/Board Member | 22/12/2020 |
| OKYO PHARMA LIMITED | Chief Executive Officer | 06/01/2021 |
Former positions of Gary Jacob
| Companies | Position | End |
|---|---|---|
| HEPION PHARMACEUTICALS, INC. | Chief Executive Officer | 18/03/2014 |
| VIRPAX PHARMACEUTICALS, INC. | Director/Board Member | 24/07/2022 |
| IMMURON LIMITED | Chief Executive Officer | 24/03/2020 |
| SYNERGY PHARMACEUTICALS INC | Chief Executive Officer | 18/12/2017 |
| Synergy Pharmaceuticals, Inc. /Old/ | Chief Executive Officer | 30/09/2017 |
Training of Gary Jacob
| University of Wisconsin | Doctorate Degree |
| University of Missouri-St. Louis | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 6 |
|---|---|
| OKYO PHARMA LIMITED | Health Technology |
| HEPION PHARMACEUTICALS, INC. | Health Technology |
| CARDIFF ONCOLOGY, INC. | Health Technology |
| IMMURON LIMITED | Health Technology |
| ACTAVIA LIFE SCIENCES, INC. | Health Technology |
| VIRPAX PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 7 |
|---|---|
Monsanto Co.
 Monsanto Co. Wholesale DistributorsDistribution Services Monsanto Co. engages in the provision of agricultural products to farmers. It provides other seed companies with genetic material and biotechnology traits for their seed brands. The company was founded by John F. Queeny in 1901 and is headquartered in St. Louis, MO. | Distribution Services |
Callisto Pharmaceuticals, Inc.
 Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | Health Technology |
| Pawfect Foods, Inc. | Retail Trade |
| Synergy Pharmaceuticals, Inc. /Old/ | Health Technology |
| G.D. Searle LLC | |
| Synergy DE | |
Synergy Pharmaceuticals LLC
 Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Synergy Pharmaceuticals LLC engages on the development and commercialization of novel gastrointestinal therapies. Its commercial product, plecanatide, is marketed under the trademark name TRULANCE, which seeks to treat adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. The company was founded by Kunwar Shailubhai and is headquartered in New York, NY. | Health Technology |
- Stock Market
- Insiders
- Gary Jacob
